INTERNAÇÕES POR COMPLICAÇÕES DE OTITE MÉDIA NO BRASIL AUMENTARAM 47,8% APÓS 2019: ESTUDO EPIDEMIOLÓGICO NACIONAL, 2016-2026

Authors

  • Mateus de Castro Paiva Centro Universitário Integrado https://orcid.org/0009-0005-1744-8607
  • Clodoaldo Fernandes dos Santos Centro Universitário Integrado
  • Damaris Lech Guerreiro Garcia de Moraes Centro Universitário Integrado
  • Débora Farina Ribeiro Centro Universitário Integrado
  • Felipe Glenn Padovani Centro Universitário Integrado
  • Gabriella Franco Feltrin Pontifícia Universidade Católica do Paraná
  • Gregório dos Reis Veiga Unicesumar - Maringá
  • Guilherme Farias Bitencourt https://orcid.org/0009-0009-3320-7044
  • Isabella de Almeida Ribeiro Centro Universitário Integrado
  • Jaqueline Martins Dutra Centro Universitário Integrado
  • Lívia Maria de Abreu Ferreira Centro Universitário Integrado https://orcid.org/0009-0006-5185-0103
  • Luyza Vitória Matos Centro Universitário Integrado https://orcid.org/0009-0003-3741-3458
  • Paulo Henrique Rangel de Moura Centro Universitário Integrado
  • Rafael Menegas de Assis Centro Universitário Integrado
  • Rafael Scaraboto Centro Universitário Integrado
  • Sara Caroline Beltrame Perez Centro Universitário Integrado
  • Thais Mayara Freitas da Silva Centro Universitário Integrado
  • Vitória Furquim Carbonera Centro Universitário Integrado https://orcid.org/0009-0000-0720-9382
  • Vitória Vital da Silva Rocha Centro Universitário Integrado
  • Yasmin Cristina da Silva Areias Centro Universitário Integrado

DOI:

https://doi.org/10.36557/2674-8169.2026v8n6p978-1002

Keywords:

Otite média, Hospitalização, Epidemiologia, Mastoidite, Saúde Pública

Abstract

Objective: To analyze the epidemiological profile of hospitalizations for complications of otitis media in Brazil between January 2016 and March 2026. Methods: Ecological, descriptive, retrospective study using secondary data from the Hospital Information System of the Brazilian Unified Health System (SIH/SUS), available through DATASUS. Hospitalizations related to "otitis media and other disorders of the middle ear and mastoid process" were analyzed from January 2016 to March 2026. Variables included number of hospitalizations, temporal and seasonal distribution, age group, sex, geographic distribution, hospital mortality, length of stay, and hospitalization costs. Results: A total of 160,485 hospitalizations were recorded, with 279 deaths and an overall mortality rate of 0.17%. A marked reduction in hospitalizations occurred during 2020-2021, followed by progressive post-pandemic growth, reaching 23,265 hospitalizations in 2025. Pediatric predominance was evident, especially among children aged 1-4 years (35,865 hospitalizations). The Southeast and Northeast regions concentrated most cases. A consistent seasonal pattern emerged, with peaks between July and November. Although children accounted for most hospitalizations, the highest absolute number of deaths occurred among individuals aged ≥80 years. Mean hospital stay was 3.4 days, and total costs exceeded R$ 93.6 million. Conclusions: Complications of otitis media remain associated with substantial hospital burden in Brazil, particularly among young children and older adults. Strong influence of respiratory seasonality and significant changes in epidemiological patterns following the COVID-19 pandemic were observed. These findings underscore the importance of early diagnosis, adequate management of respiratory infections, and strengthening preventive strategies. 

Downloads

Download data is not yet available.

References

ALLEN, D. Z. et al. Impact of COVID-19 on nationwide pediatric otolaryngology: otitis media and myringotomy tube trends. American Journal of Otolaryngology, v. 43, n. 2, p. 103369, 2022. DOI: 10.1016/j.amjoto.2021.103369.

BERMAN-ROSA, M. et al. Effectiveness of the 10-valent pneumococcal conjugate vaccine (PCV10) in children: evidence from a systematic review and meta-analysis. Vaccine, v. 38, n. 42, p. 6628-6636, 2020. DOI: 10.1016/j.vaccine.2020.07.064.

DAGAN, R. et al. Effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonisation of antibiotic-non-susceptible Streptococcus pneumoniae. The Lancet Infectious Diseases, v. 21, n. 7, p. 1023-1035, 2021. DOI: 10.1016/S1473-3099(20)30909-2.

DUYGU, E.; ŞEVIK ELIÇORA, S. Our experience on the management of acute mastoiditis in pediatric acute otitis media patients. International Journal of Pediatric Otorhinolaryngology, v. 138, p. 110372, 2020. DOI: 10.1016/j.ijporl.2020.110372.

FAVRE, N.; PATEL, V. A.; CARR, M. M. Complications in pediatric acute mastoiditis: HCUP KID analysis. Otolaryngology--Head and Neck Surgery, v. 165, n. 5, p. 722-730, 2021. DOI: 10.1177/0194599821989633.

GBD 2021 UPPER RESPIRATORY INFECTIONS OTITIS MEDIA COLLABORATORS. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases, v. 25, n. 2, p. e89-e124, 2025. DOI: 10.1016/S1473-3099(24)00403-7.

HULLEGIE, S. et al. A strong decline in the incidence of childhood otitis media during the COVID-19 pandemic in the Netherlands. Frontiers in Cellular and Infection Microbiology, v. 11, p. 768377, 2021. DOI: 10.3389/fcimb.2021.768377.

IZURIETA, P. et al. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Review of Vaccines, v. 21, n. 11, p. 1631-1650, 2022. DOI: 10.1080/14760584.2022.2114900.

KØRVEL-HANQUIST, A. et al. Risk of acute otitis media in children with cleft palate in Denmark. The Cleft Palate-Craniofacial Journal, v. 55, n. 4, p. 596-601, 2018. DOI: 10.1177/1055665617735102.

LIEBERTHAL, A. S. et al. The diagnosis and management of acute otitis media. Pediatrics, v. 131, n. 3, p. e964-e999, 2013. DOI: 10.1542/peds.2012-3488.

MAROM, T. et al. Trends in pediatric acute otitis media burden during the first COVID-19 year. Otology & Neurotology, v. 43, n. 7, p. e760-e766, 2022. DOI: 10.1097/MAO.0000000000003581.

PEYSER-ROSENBERG, M. et al. Shifting patterns of acute otitis media and mastoiditis through COVID-19 era: analysis of pre-pandemic, pandemic, and post-pandemic dynamics. European Archives of Oto-Rhino-Laryngology, 2025. DOI: 10.1007/s00405-025-09296-x.

SHAIKH, N. Otitis media in young children. The New England Journal of Medicine, v. 392, n. 14, p. 1418-1426, 2025. DOI: 10.1056/NEJMcp2400531.

SMOLINSKI, N. E. et al. Antibiotic treatment to prevent pediatric acute otitis media infectious complications: a meta-analysis. PLoS One, v. 19, n. 6, p. e0304742, 2024. DOI: 10.1371/journal.pone.0304742.

VENEKAMP, R. P. et al. Antibiotics for acute otitis media in children. The Cochrane Database of Systematic Reviews, v. 11, p. CD000219, 2023. DOI: 10.1002/14651858.CD000219.pub5.

WANNARONG, T. et al. Pneumococcal conjugate vaccines for preventing acute otitis media in children: a systematic review and network meta-analysis. The Pediatric Infectious Disease Journal, v. 42, n. 11, p. 1003-1011, 2023. DOI: 10.1097/INF.0000000000004063.

WARNER, B. K. et al. Global otitis media incidence changes during the COVID pandemic: systematic review and meta-analysis.

Published

2026-06-17

How to Cite

Paiva, M. de C., Santos, C. F. dos, Moraes, D. L. G. G. de, Ribeiro, D. F., Padovani, F. G., Feltrin, G. F., Veiga, G. dos R., Bitencourt, G. F., Ribeiro, I. de A., Dutra, J. M., Ferreira, L. M. de A., Matos, L. V., Moura, P. H. R. de, Assis, R. M. de, Scaraboto, R., Perez, S. C. B., Silva, T. M. F. da, Carbonera, V. F., Rocha, V. V. da S., & Areias, Y. C. da S. (2026). INTERNAÇÕES POR COMPLICAÇÕES DE OTITE MÉDIA NO BRASIL AUMENTARAM 47,8% APÓS 2019: ESTUDO EPIDEMIOLÓGICO NACIONAL, 2016-2026 . Brazilian Journal of Implantology and Health Sciences, 8(6), 978–1002. https://doi.org/10.36557/2674-8169.2026v8n6p978-1002